Show simple item record

dc.contributor.authorD'Urzo, Anthony
dc.contributor.authorDonohue, James F
dc.contributor.authorKardos, Peter
dc.contributor.authorMiravitlles, Marc
dc.contributor.authorPrice, David
dc.date.accessioned2016-01-28T10:19:06Z
dc.date.available2016-01-28T10:19:06Z
dc.date.issued2015
dc.identifier54731025
dc.identifierc1479561-2930-4bd5-9c9b-12b2c97ef57c
dc.identifier26194213
dc.identifier84937721581
dc.identifier.citationD'Urzo , A , Donohue , J F , Kardos , P , Miravitlles , M & Price , D 2015 , ' A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease ' , Expert Opinion on Pharmacotherapy , vol. 16 , no. 12 , pp. 1845-1860 . https://doi.org/10.1517/14656566.2015.1067682en
dc.identifier.urihttp://hdl.handle.net/2164/5448
dc.format.extent16
dc.format.extent723064
dc.language.isoeng
dc.relation.ispartofExpert Opinion on Pharmacotherapyen
dc.subjectchronic obstructive pulmonary diseaseen
dc.subjectinhaled corticosteroiden
dc.subjectlong-acting muscarinic antagonisten
dc.subjectlong-acting β2-agonisten
dc.subjectRM Therapeutics. Pharmacologyen
dc.subject.lccRMen
dc.titleA re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary diseaseen
dc.typeJournal itemen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.identifier.doi10.1517/14656566.2015.1067682


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record